Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

China Pharma Holdings Inc. (CPHI)

0.4547   -0.045 (-9.06%) 02-14 15:59
Open: 0.499 Pre. Close: 0.5
High: 0.499 Low: 0.45
Volume: 1,296,552 Market Cap: 20M
China Pharma Holding Inc develops, manufactures and markets pharmaceutical products for human use in connection with a high-incidence and high-morality diseases and medical conditions in the People's Republic of China.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.501 - 0.504 0.504 - 0.506
Low: 0.442 - 0.446 0.446 - 0.449
Close: 0.445 - 0.45 0.45 - 0.454

Technical analysis

as of: 2020-02-14 4:27:38 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.82     One year: 1.12
Support: Support1: 0.28    Support2: 0.23
Resistance: Resistance1: 0.70    Resistance2: 0.96
Pivot: 0.53
Moving Average: MA(5): 0.50     MA(20): 0.49
MA(100): 0.30     MA(250): 0.30
MACD: MACD(12,26): 0.05     Signal(9): 0.07
Stochastic oscillator: %K(14,3): 21.13     %D(3): 26.35
RSI: RSI(14): 49.75
52-week: High: 0.96  Low: 0.21  Change(%): 68.4
Average Vol(K): 3-Month: 215047  10-Days: 713286

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CPHI has closed above bottom band by 34.5%. Bollinger Bands are 362.1% wider than normal. The large width of the bands suggest high volatility as compared to CPHI's normal range. The bands have been in this wide range for 28 bars. This is a sign that the current trend might continue.

Headline News

Introducing China Pharma Holdings (NYSEMKT:CPHI), A Stock That Climbed 37% In The Last Three Years
Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are…

China Pharma Holdings, Inc. (CPHI) CEO Zhilin Li on Q1 2019 Results - Earnings Call Transcript
China Pharma Holdings, Inc. (NYSEMKT:CPHI) Q1 2019 Earnings Conference Call May 15, 2019 8:30 A.M. ET Company Participants Diana Huang - Investor Relations, Man

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 43.58
Shares Float (M) 21.94
% Held by Insiders 49.66
% Held by Institutions 2.07
Shares Short (K) 10
Shares Short P. Month (K)

Stock Financials

EPS -0.219
Book Value (p.s.) 0.630
PEG Ratio
Profit Margin -85.88
Operating Margin -24.86
Return on Assets (ttm) -3.7
Return on Equity (ttm) -29.4
Qtrly Rev. Growth 3.4
Gross Profit (p.s.) 0.045
Sales Per Share
EBITDA (p.s.) 0.006
Qtrly Earnings Growth
Operating Cash Flow (M) 1.65
Levered Free Cash Flow (M) 5.35

Stock Valuations

P/E -2.08
P/E Growth Ratio -0.09
P/BV 0.72
P/S 1.81
P/CF 12.01

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -0.55
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.